Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 7, 2026

January 7, 2026

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

GlobeNewswire

January 7, 2026

Kraig Biocraft Laboratories Takes Possession of Three Strategic Mulberry Fields Advancing Massive Spider Silk Production Ramp-Up

GlobeNewswire

January 7, 2026

Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence

GlobeNewswire

January 7, 2026

Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 7, 2026

Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance

GlobeNewswire

January 7, 2026

EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026

GlobeNewswire

January 7, 2026

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

GlobeNewswire

January 7, 2026

BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs

GlobeNewswire

January 7, 2026

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®

GlobeNewswire

January 7, 2026

Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline

GlobeNewswire

January 7, 2026

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

GlobeNewswire

January 7, 2026

Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week

GlobeNewswire

January 7, 2026

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

GlobeNewswire

January 7, 2026

Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China

GlobeNewswire

January 7, 2026

RadNet Expands to Southwest Florida with Acquisition of Radiology Regional

GlobeNewswire

January 7, 2026

ExamWorks Announces Strategic Leadership Transition Plan to Further Accelerate Long-Term Growth

GlobeNewswire

January 7, 2026

RadNet Names Four Leaders to Expanded Executive Roles

GlobeNewswire

January 7, 2026

Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

GlobeNewswire

January 7, 2026

DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies

GlobeNewswire

January 7, 2026

LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies

GlobeNewswire